FDA Approves Amgen's RIABNI™ (rituximab-arrx), A Biosimilar To Rituxan® (rituximab)

Author's Avatar
Dec 17, 2020
Article's Main Image

Fifth FDA Approval From Amgen's Biosimilars Portfolio

PR Newswire